These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 19171384)
1. Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study. Anderson IM; Sarsfield A; Haddad PM J Affect Disord; 2009 Sep; 117(1-2):116-9. PubMed ID: 19171384 [TBL] [Abstract][Full Text] [Related]
2. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial. Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
5. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. McManus DQ; Arvanitis LA; Kowalcyk BB J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435 [TBL] [Abstract][Full Text] [Related]
6. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Buckley PF Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183 [TBL] [Abstract][Full Text] [Related]
8. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation. Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641 [TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688 [TBL] [Abstract][Full Text] [Related]
11. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W; Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216 [TBL] [Abstract][Full Text] [Related]
13. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder]. György B; Robert K; László C; Andrea J; Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015 [TBL] [Abstract][Full Text] [Related]
14. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. Paleacu D; Barak Y; Mirecky I; Mazeh D Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256 [TBL] [Abstract][Full Text] [Related]
15. An open-label study of quetiapine in anorexia nervosa. Bosanac P; Kurlender S; Norman T; Hallam K; Wesnes K; Manktelow T; Burrows G Hum Psychopharmacol; 2007 Jun; 22(4):223-30. PubMed ID: 17487935 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936 [TBL] [Abstract][Full Text] [Related]
18. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. Baune BT; Caliskan S; Todder D Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266 [TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
20. Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study. Bahk WM; Yoon BH; Lee KU; Chae JH Hum Psychopharmacol; 2004 Apr; 19(3):181-5. PubMed ID: 15079852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]